Overview

The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
To assess the pharmacokinetic Interaction between CKD-501 and sulfonylurea (Glimepiride) in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Glimepiride